Evidence map›Paper›PMID 28771198›Full record

ReviewInternational journal of molecular sciences2017

Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond.

Tetsuya Tsukamoto, Mitsuru Nakagawa, Yuka Kiriyama, Takeshi Toyoda, Xueyuan Cao

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. Optimized sequential therapyWorld journal of gastroenterology · 2024
    Trial
  3. Frontiers in immunology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Helicobacter pylori upregulates circPGD and promotes development of gastric cancer.Journal of cancer research and clinical oncology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Tetsuya TsukamotoDepartment of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake 470-1192, Japan. ttsukamt@fujita-hu.ac.jp.
Mitsuru NakagawaDepartment of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake 470-1192, Japan. nakaga1@fujita-hu.ac.jp.
Yuka KiriyamaDepartment of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake 470-1192, Japan. ykiri@fujita-hu.ac.jp.
Takeshi ToyodaDivision of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan. t-toyoda@nihs.go.jp.
Xueyuan CaoDepartment of Gastric and Colorectal Surgery, Jilin University, Changchun 130000, China. caoxueyuan19680414@yahoo.co.jp.
Fujita Health University · JPJilin University · CNNational Institute of Health Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although its prevalence is declining, gastric cancer remains a significant public health issue. The bacterium

Indexed as

Helicobacter pyloriAnimalsHelicobacter InfectionsHumansStomach Neoplasmschemopreventionchronic atrophic gastritiseradicationHelicobacter pyloriintestinal metaplasia

Identifiers

PMID28771198
PMCPMC5578089
OpenAlexW2742765655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.